Pedaling away chemo pain: cycling study offers hope
NCT ID NCT07150117
First seen Sep 30, 2025 · Last updated Jun 19, 2026 · Updated 42 times
Summary
This study tests if a supervised cycling program can reduce nerve pain caused by chemotherapy. Thirty adults with cancer will ride a stationary bike twice a week for 12 weeks. Researchers will check if the exercise is safe, enjoyable, and helps with symptoms and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cross Cancer Institute
RECRUITINGEdmonton, Alberta, T6G 1Z2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
supervised cycling-based aerobic exercise
What this could lead to
If this works, it could point toward a simple, drug-free way to manage nerve pain from chemotherapy.
What could go wrong
This is a very small, early proof-of-concept study, not a large trial. It may not show clear benefits, and results may not apply to everyone with nerve pain.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.